Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Lilly to sell manufacturing site to Evonik Industries

Lilly to sell manufacturing site to Evonik Industries

15th October 2009

Lilly has announced its plans to sell one of its manufacturing sites to Evonik Industries – one of the largest chemical firms in the world.

As a result of the agreement, which includes a multi-year supply and services agreement, the 700 employees at the firms’ site will be offered employment with Evonik.

The facility will continue to operate, producing high-quality active pharmaceutical ingredients and specialty chemical and animal health products.

“At Lilly, we are taking the steps necessary to ensure our long-term success by becoming a leaner, more focused, more customer-oriented and more competitive company,” explained John Lechleiter, Lilly’s chairman and chief executive officer.

Last month, Lilly entered into a partnership with Academia Sinica, which will see the foundation contribute to the company’s Tuberculosis Drug Discovery Initiative.

The two organisations will also cooperate on target-based screening for the discovery of new tuberculosis cases.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.